SEARCH · Engineering Papers
Results for “anaerobic”
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
The implications of facility design and enabling policies on the economics of dry anaerobic digestion
Not Available
Pristane promotes anaerobic glycolysis to facilitate proinflammatory activation of macrophages and development of arthritis
Highlights: • Pristane-induced arthritis is dependent on macrophages with M1 phenotype. • Pristane causes mitochondrial dysfunction and metabolic abnormalities in macrophages. • Macrophages treated by pristane show increased glycolysis flux and enzyme activity. • Metabolic reprogramming of macrophages controls M1 polarization and arthritis. Pristane-induced arthritis (PIA) could be adoptively transferred by splenic T cells in rats, and innate immunity should play critical roles in T cell activation. However, in pre-clinical stage, the activation mechanism of innate cells like macrophages remains unclear. Here we found that PIA was dependent on macrophages since cell depletion alleviated disease severity. Splenic macrophages of PIA rats showed M1 phenotypic shifting. The quantitative proteomics analysis suggested that macrophages initiated metabolic reprogramming with the conversion of aerobic oxidation to glycolysis in response to pristane in vivo. Notably, macrophages treated with pristane showed mitochondrial dysregulation and increased glycolysis flux and enzyme activity. Additionally, TNFα production, strongly associating with the glycolysis enzyme Ldha/Ldhb, could be reduced as glycolysis was inhibited or be enhanced as citrate cycle was blocked. This work provides detailed insights into the molecular mechanisms of pristane-mediated metabolic reprogramming in macrophages and suggests a new therapeutic strategy for arthritic disorders.
Role of cyanobacterial phosphoketolase in energy regulation and glucose secretion under dark anaerobic and osmotic stress conditions
Not Available
A SWEET surprise: Anaerobic fungal sugar transporters and chimeras enhance sugar uptake in yeast
Not Available
Transformation and Mobility of Cu, Zn, and Cr in Sewage Sludge during Anaerobic Digestion with Pre-
Explore the source record for details and available documents.
Catalytic Light Alkanes Conversion through Anaerobic Ammodehydrogenation
Catalytic transformation of light alkanes could have considerable practical value, yet remains one of the most challenging areas in catalysis research due to the inertness of the C–H bond. Here, we proposed an efficient ammodehydrogenation (ADeH) catalytic system for the direct C–N linkage between light alkanes and ammonia for CH 3 CN and H 2 (CO x free) production. This breakthrough is achieved over bifunctional metal-modified HZSM-5 catalysts, through the tandem dehydrogenation–amination–dehydrogenation mechanism. We show that ethane ADeH over the Pt/HZSM-5 catalyst can be realized under atmospheric pressure at temperatures as low as 350 °C. The specific rate of CH 3 CN is ~60 μmol/(g min), and the selectivity is up to 99% under such mild conditions. The yield of CH 3 CN increases with increasing temperature; however, the selectivity decreases due to the formation of HCN, C 2 H 4 , and CH 4 . Additionally, the Pt/HZSM-5 catalyst is coke-resistant during the ADeH owing to the strong interaction between NH 3 and the acid sites of the catalyst. So, we anticipate that the proposed ADeH could be extended for the transformation of various n/iso-alkanes with tunable selectivity to alkene and nitriles.
Discovery of a Cyclic Choline Analog That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria
Abstract not provided
Characterization of Methyl- and Acetyl-Ni Intermediates in Acetyl CoA Synthase Formed during Anaerobic CO 2 and CO Fixation
Not Available
Structure-Guided Identification of a Small Molecule That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria
Abstract not provided
Anaerobic methanotroph ‘Candidatus Methanoperedens nitroreducens’ has a pleomorphic life cycle
Not provided.
A molten carbonate shell modified perovskite redox catalyst for anaerobic oxidative dehydrogenation of ethane
Acceptor-doped, redox-active perovskite oxides such as La 0.8 Sr 0.2 FeO 3 (LSF) are active for ethane oxidation to CO x but show poor selectivity to ethylene. This article reports molten Li 2 CO 3 as an effective “promoter” to modify LSF for chemical looping–oxidative dehydrogenation (CL-ODH) of ethane. Under the working state, the redox catalyst is composed of a molten Li 2 CO 3 layer covering the solid LSF substrate. The molten layer facilitates the transport of active peroxide (O 2 2- ) species formed on LSF while blocking the nonselective sites. Spectroscopy measurements and density functional theory calculations indicate that Fe 4+ →Fe 3+ transition is responsible for the peroxide formation, which results in both exothermic ODH and air reoxidation steps. With >90% ethylene selectivity, up to 59% ethylene yield, and favorable heat of reactions, the core-shell redox catalyst has an excellent potential to be effective for intensified ethane conversion. The mechanistic findings also provide a generalized approach for designing CL-ODH redox catalysts.
Alkali metal halide–coated perovskite redox catalysts for anaerobic oxidative dehydrogenation of n -butane
Oxidative dehydrogenation (ODH) of n-butane has the potential to efficiently produce butadiene without equilibrium limitation or coke formation. Despite extensive research efforts, single-pass butadiene yields are limited to <23% in conventional catalytic ODH with gaseous O 2 . This article reports molten LiBr as an effective promoter to modify a redox-active perovskite oxide, i.e., La 0.8 Sr 0.2 FeO 3 (LSF), for chemical looping–oxidative dehydrogenation of n-butane (CL-ODHB). Under the working state, the redox catalyst is composed of a molten LiBr layer covering the solid LSF substrate. Characterizations and ab initio molecular dynamics (AIMD) simulations indicate that peroxide species formed on LSF react with molten LiBr to form active atomic Br, which act as reaction intermediates for C–H bond activation. Meanwhile, molten LiBr layer inhibits unselective CO 2 formation, leading to 42.5% butadiene yield. The redox catalyst design strategy can be extended to CL-ODH of other light alkanes such as iso-butane conversion to iso-butylene, providing a generalized approach for olefin production.
The global anaerobic metabolism regulator fnr is necessary for the degradation of food dyes and drugs by Escherichia coli
ABSTRACT The microbiome is an underappreciated contributor to intestinal drug metabolism with broad implications for drug efficacy and toxicity. While considerable progress has been made toward identifying the gut bacterial genes and enzymes involved, the role of environmental factors in shaping their activity remains poorly understood. Here, we focus on the gut bacterial reduction of azo bonds (R-N = N-R’), found in diverse chemicals in both food and drugs. Surprisingly, the canonical azoR gene in Escherichia coli was dispensable for azo bond reduction. Instead, azoreductase activity was controlled by the fumarate and nitrate reduction ( fnr ) regulator, consistent with a requirement for the anoxic conditions found within the gastrointestinal tract. Paired transcriptomic and proteomic analysis of the fnr regulon revealed that in addition to altering the expression of multiple reductases, FNR is necessary for the metabolism of L-Cysteine to hydrogen sulfide, enabling the degradation of azo bonds. Furthermore, we found that FNR indirectly regulates this process through the small noncoding regulatory RNA fnrS . Taken together, these results show how gut bacteria sense and respond to their intestinal environment to enable the metabolism of chemical groups found in both dietary and pharmaceutical compounds. IMPORTANCE This work has broad relevance due to the ubiquity of dyes containing azo bonds in food and drugs. We report that azo dyes can be degraded by human gut bacteria through both enzymatic and nonenzymatic mechanisms, even from a single gut bacterial species. Furthermore, we revealed that environmental factors, oxygen, and L-Cysteine control the ability of E. coli to degrade azo dyes due to their impacts on bacterial transcription and metabolism. These results open up new opportunities to manipulate the azoreductase activity of the gut microbiome through the manipulation of host diet, suggest that azoreductase potential may be altered in patients suffering from gastrointestinal disease, and highlight the importance of studying bacterial enzymes for drug metabolism in their natural cellular and ecological context.